BXN — Bioxyne Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro CapFalling Star
- AU$8.32m
- AU$6.29m
- AU$2.11m
Annual balance sheet for Bioxyne, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2017 June 30th | C2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 3.88 | 3.31 | 1.77 | 1.75 | 1.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.537 | 0.684 | 0.779 | 0.318 | 0.364 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 4.51 | 4.73 | 3.52 | 3.07 | 2.51 |
Net Property, Plant And Equipment | 0.003 | 0.161 | 0.209 | 0.235 | 0.138 |
Net Intangible Assets | |||||
Total Assets | 4.74 | 5.05 | 3.97 | 3.34 | 2.68 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.61 | 0.729 | 0.829 | 0.726 | 0.745 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.61 | 0.729 | 0.882 | 0.779 | 0.798 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 4.13 | 4.32 | 3.09 | 2.56 | 1.88 |
Total Liabilities & Shareholders' Equity | 4.74 | 5.05 | 3.97 | 3.34 | 2.68 |
Total Common Shares Outstanding |